Physician profile
Barry G Crowe
NPI 1710964739
$736.56
in general payments reported to CMS, 2019-2025
14 companies · $28.49 in 2025
The $28.49 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.30 · 2020: $62.73 · 2021: $148 · 2022: $193 · 2023: $76.50 · 2024: $148 · 2025: $28.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $239.06 | 2019-2024 | Sapien 3 Ultra Resilia |
| Medical Device Business Services, INC. | $84.84 | 2022 | |
| Atricure, INC. | $84.34 | 2023-2025 | Synergy Ablation System |
| Actelion Pharmaceuticals US, INC. | $75.99 | 2021-2022 | |
| Ethicon US, LLC | $62.71 | 2021-2025 | Prolene, Vistaseal, Dermabond Prineo |
| Amarin Pharma, INC. | $36.37 | 2020 | |
| Amgen INC. | $25.21 | 2019-2020 | |
| Baxter Healthcare | $24.41 | 2023 | Biosurgery - Floseal |
| Medtronic, INC. | $22.31 | 2022 | |
| Getinge USA Sales, LLC | $18.59 | 2019 | |
| Artivion, INC. | $17.66 | 2022 | |
| Braemar Manufacturing, LLC | $15.76 | 2019 | |
| Irhythm Technologies, INC. | $15.28 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Crowe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.